SCHEMBL23966537

SCHEMBL23966537

CCOC(=O)c1cn(Cc2nc3cc(OCC(F)F)c(C#N)cc3n2COCC[SiH](C)C)c2ccccc2c1=O

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.36
HSD17B10 Q99714 1/20 0.36
AR P10275 1/20 0.36
TDP1 Q9NUW8 2/20 0.33
P2RX3 P56373 1/20 0.33
PKM P14618 1/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
KMT2A Q03164 2/20 0.31
F2RL3 Q96RI0 1/20 0.31
RAB9A P51151 2/20 0.31
GALR3 O60755 1/20 0.31
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909032 0.92 HTT (0.36) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23915348 0.91 HSD17B10 (0.36) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23966538 0.91 HTT (0.36) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23914625 0.89 HTT (0.36) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23915349 0.89 HSD17B10 (0.36) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23909123 0.79 S1PR2 (0.40) HTTHSD17B10ARTDP1P2RX3
SCHEMBL23908833 0.69 S1PR2 (0.44) LMNATSHRALDH1A1SMN1; SMN2RAB9A
SCHEMBL23908886 0.68 PARP1 (0.36) ARLMNATSHRNPC1
SCHEMBL23915472 0.66 XDH (0.32)
SCHEMBL23966523 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed